Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Ludwig Cancer Research engages leading scientists and clinicians in an integrated effort to understand and confront the challenge of cancer. The Oxford Branch is based at the University of Oxford, UK and benefits from excellent links with the global Ludwig Cancer Research and local Oxford research communities.

Ludwig Oxford Branch researchers are investigating all stages of cancer, from the risk of disease through to new treatment opportunities. Our research groups are interested in the signalling pathways that influence cancer initiation and progression, with a focus on infection, inflammation and cancer epigenetics. We aim to advance cancer prevention, early diagnosis and effective treatment. Find out more about the Ludwig Oxford research groups.

Seminars

Multi-omic spatially resolved landscape of South Asian British, Black British and White British breast cancers

Thursday, 28 May 2026, 11am to 12pm

Speaker(s): Dr Kairbaan Hodivala-Dilke

Somatic mitochondrial DNA mutations in cancer: prevalent and relevant

Monday, 22 June 2026, 11am to 12pm

Speaker(s): Prof Payam Gammage

conference

Follow Ludwig Cancer

Follow NDM